Abstract:Background: Falls among the elderly are an issue internationally and a public health problem that brings substantial economic and quality-of-life burdens to individuals and society. Falls prevention is an important measure of nursing quality and patient safety. Numerous studies have evaluated the association of medication use with fall risk in elderly patients. However, an up-to-date review has not been available to summarize the multifaceted pharmaceutical concerns in the prevention of medication-related falls. Materials and methods: Relevant literature was identified by performing searches in PubMed, Web of Science, and the Cochrane Library, covering the period until February 2014. We included studies that described an association between medications and falls, and effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and pharmacological interventions on fall risk in elderly patients. The full text of each included article was critically reviewed, and data interpretation was performed. Results: Fall-risk-increasing drugs (FRIDs) include central nervous system-acting agents, cough preparations, nonsteroidal anti-inflammatory drugs, anti-Alzheimer’s agents, antiplatelet agents, calcium antagonists, diuretics, α-blockers, digoxin, hypoglycemic drugs, neurotoxic chemotherapeutic agents, nasal preparations, and antiglaucoma ophthalmic preparations. The degree of medication-related fall risk was dependent on one or some of the following factors: drug pharmacokinetic/pharmacodynamic properties (eg, elimination half-life, metabolic pathway, genetic polymorphism, risk rating of medications despite belonging to the same therapeutic class) and/or characteristics of medication use (eg, number of medications and drug–drug interactions, dose strength, duration of medication use and time since stopping, medication change, prescribing appropriateness, and medication adherence). Pharmacological interventions, including withdrawal of FRIDs, pharmacist-conducted clinical medication review, and computerized drug alerts, were effective in reducing fall risk. Conclusion: Based on the literature review, clear practical recommendations for clinicians to prevent falls in the elderly included making a list of FRIDs, establishing a computerized alert system for when to e-prescribe FRIDs, seeking an alternative drug with lower fall risk, withdrawing FRIDs if clinically indicated, taking pertinent cautions when the use of FRIDs cannot be avoidable, paying attention to prescribing appropriateness, simplifying the medication regimen, strengthening pharmacist-conducted clinical medication review, ensuring the label of each FRID dispensed contains a corresponding warning sign, being careful when medication change occurs, enhancing medication adherence, and mandating for periodic reassessment of potential risk associated with the patient's medication regimen. Further studies should be conducted in this area, such as investigating whether medication reconciliation and improving medication adherence could decrease the rate of falls. Keywords: falls, geriatrics, medication, medication adherence, prescribing, risk, safe medication use

Association of fall risk-increasing drugs with falls in generally healthy older adults: a 3-year prospective observational study of the DO-HEALTH trial

Effects of Drug Pharmacokinetic/pharmacodynamic Properties, Characteristics of Medication Use, and Relevant Pharmacological Interventions on Fall Risk in Elderly Patients.

Factors associated with fall risk increasing drug use in older black and white men and women: the Health ABC Study

Prescribing Patterns of Fall Risk-Increasing Drugs (frids) in Older Adults Hospitalized for Heart Failure

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

Effect of number of medications on the risk of falls among community‐dwelling older adults: A 3‐year follow‐up of the SONIC study

Pharmacist intervention is associated with fewer serious falls over 3 months among older fallers at a day hospital: A quasi-experimental study

Associations between doses of fall-risk-increasing drugs (FRIDs) and falls of hospitalized patients

Initiative to deprescribe high‐risk drugs for older adults presenting to the emergency department after falls

Falls in hospitalized older adults and the use of fall risk-increasing drugs and anticholinergic medications in Colombia: a case‒control study

Prevalence of medication-related falls in 200 consecutive elderly patients with hip fractures: a cross-sectional study

A quantitative study on the impact of a community falls pharmacist role, on medicines optimisation in older people at risk of falls

Short-term Medication Effect on Fall Risk in Multimorbid Inpatients with Dementia

Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk-Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial

Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults

Reducing Central Nervous System-Active Medications to Prevent Falls and Injuries Among Older Adults: A Cluster Randomized Clinical Trial

The risk of falls in older people prescribed antihypertensives ... and other research

Does living alone influence fall risk among Swiss older adults aged 60+? A pooled observational analysis of three RCTs on fall prevention

High rate of potentially inappropriate medication use in older people: a case–control study

A meta-analysis of previous falls and subsequent fracture risk in cohort studies

Fall Prevention in a Primary Care Setting